Metabolon Names Andrew Messick Chief Financial Officer
2026-02-03 - 16:38
Seasoned life sciences finance leader brings deep expertise in operational excellence and M&A to support Metabolon’s next stage of growth MORRISVILLE, N.C., Feb. 3, 2026 /PRNewswire/ — Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, announces the appointment of
Share this post: